A first-line regimen involving pembrolizumab (Keytruda) and olaparib (Lynparza) significantly reduced the risk of disease ...

Promising therapies for platinum-resistant ovarian cancer produced mixed results in separate trials. The AKT inhibitor ...

A clinician nudge for referral to a gynecologic oncologist at the time of suspected ovarian cancer diagnosis improved referral rates by 20 percentage points, according to study results.Nearly a third ...

Ovarian cancer is the sixth most common form of cancer in women in the UK - and four symptoms could be signs. One symptom can ...

Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment paradigms in ovarian cancer.

Watch the complete video to know the warning signs that the body may send when you are suffering from ovarian cancer. It ...

AbbVie has reported analysis from a Phase III trial that assessed Elahere against chemotherapy for platinum-resistant ovarian ...

Ovarian cancer is often diagnosed late because its symptoms resemble those of less serious conditions. As a result, only 20% ...

Pitt research uncovers new insights into ovarian cancer origins, shedding light on potential early detection and treatment ...

An ovarian cancer campaigner, fundraiser and survivor from Norfolk who has taken her story to parliament, is raising awareness of ovarian cancer and the importance of getting checked if something ...